Send us a Message

*
*
*
*

Guildford, UK

ID Business Solutions Ltd.

2 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7QB
United Kingdom

Tel: +44 1483 595 000
Fax: +44 1483 595 001

London, UK

ID Business Solutions Ltd.

4th Floor, Pembroke Building
Kensington Village
Avonmore Road
London, W14 8DG
United Kingdom

Tel: +44 207 565 8620
Fax: +44 208 237 8441

Paris, France

ID Business Solutions Ltd.

18 Rue Pasquier,
Paris, 75008
France

Tel: +33 01 78 41 44 46

Alameda, California

ID Business Solutions Inc.

1301 Marina Village Parkway
Suite 320,
Alameda, CA 94501

Tel: +1 510 814 4900
Fax: +1 510 814 4910

Bridgewater, New Jersey

ID Business Solutions Inc.

750 US Highway 202,
Suite 200,
Bridgewater, NJ 08807

Tel: +1 908 429 2900
Fax: +1 908 429 2901

Burlington, Massachusetts

ID Business Solutions Inc.

25 Burlington Mall Road
1st Floor, Suite #107
Burlington, MA 01803

Tel: +1 781 272 3355
Fax: +1 781 272 3377

Tokyo, Japan

ID Business Solutions (Japan)

Shibuya Mark City W22F
1-12-1 Dogenzaka Shibuya-ku Tokyo
150-0043 Japan

Tel: +81 3 4360 5344
info-japan@idbs.com

Mumbai, India

Trident Equipments Pvt Ltd

F409/410 Kailas Industrial Complex
Park Site, Vikhroli(W)
Mumbai, 400079
India

David Morris - DMorris@idbs.com
Tel: +912225181705

Shanghai, China

ID Business Solutions

Room 207, Block A, Innovation Building
NO.333 Cailun Road, Zhangjiang High Tech. Park
Shanghai 201203
China

Tel: +86-21-6468-5535/6469-1770
Fax: +86-21-6468-5366

Melbourne, Australia

Conor Higgins
PO box 9079
Brighton
Melbourne
Vic 3186

Conor Higgins - chiggins@idbs.com
Tel: +61 410 708 052

Close

IDBS Press Release

Institut Pasteur Korea selects ActivityBase as its Screening Solution of choice

New Research Center in Korea employs ActivityBase for High Content Screening (HCS)

Guildford, United Kingdom, Sep 18, 2006 - IDBS today announced that Institut Pasteur - Korea has implemented the ActivityBase data management software suite to increase efficiency and throughput in its screening operations.

Institut Pasteur Korea (IP-K), a new Research Center located in Seoul, South Korea, has purchased ActivityBase to handle their biology and chemistry data for High Throughput and High Content Screening (HTS/HCS). IP-K is implementing HCS assays and platforms for Drug Discovery using cell-based models of disease and automated confocal microscopy. IP-K will use ActivityBase suite to consolidate chemistry information and screening results, including those from microscopy-based screens, in a single Oracle database. Institut Pasteur Korea decided to purchase ActivityBase as its researchers felt more secure with a system with a proven track record in Drug Discovery.

Dr. Thierry Christophe, the Head of the Screening and Pharmacology lab, has used ActivityBase in previous positions at other companies. He said "I am happy to be working with ActivityBase again, as it is a robust and flexible system that I know can deliver the results we need. We plan to develop specific data analysis templates for High Content Screens allowing the manipulation of multiplexing data from one single screen."

Neil Kipling, IDBS' Chairman and CEO, commented: "The increase in HCS and HTS planned by IP-K's screening group demanded a data management system that could scale up to their requirements, both now and in the future, as well as map closely to their workflow. We are delighted to be supporting a centre of excellence in biomedical research and technology development, allowing new drugs to be identified faster and more reliably."

About IDBS

IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximising the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.

Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide.

About Institut Pasteur, Korea
Institut Pasteur Korea (IP-Korea) was created in 2004 with the strategic focus of developing enabling technologies and therapeutics to combat disease. In order to meet this goal, IP-Korea is developing High Throughput assays using high content visual screens. IP-Korea takes advantage of its position as a nexus of biology, image mining, new microscopy development and medicinal and nano chemistry research.
IP-Korea is a part of the International Network of Pasteur Institutes, which gives IP-Korea access to research developed throughout the 29 partner Institutes. In addition, IP-Korea has agreements with the French CNRS (Centre National pour le Recherche Scientifique), KRICT (Korea Research Institute of Chemical Technology) and KIST (Korea Institute of Science and Technology) further increasing its research capabilities.
IP-Korea is developing cell-based assays allowing potential drugs to be selected by their ability to reverse disease phenotypes. To this end, IP-Korea has implemented the first worldwide uHTS platform from Evotec Technologies in a BSL-3 facility that includes an automatized confocal microscope (Opera) as well as fluorescence/luminescence readers.
For more information, please contact Dr. Philip Bernstein (philip.bernstein@pasteur.or.kr) or visit http://www.ip-korea.org.
Institut Pasteur Korea is a non-profit organization based in Seoul, South Korea.

For media enquiries, please contact:

Danielle Guinebertiere, IDBS Communications Director
Tel: +1-617-547-2500 ext 230
Email: dguinebertiere@idbs.com